Eric K. Nguyen

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Researcher

University of Central Arkansas

Also affiliated: Creighton University (2020); Fundación Juan March (2007); St. Joseph Hospital (2017–2018); Sunnybrook Health Science Centre (2022–2023); NewYork–Presbyterian Brooklyn Methodist Hospital (2004); University of Ottawa (2015–2017); SUNY Downstate Health Sciences University (2004); Truven Health Analytics (United States) (2017); Juravinski Cancer Centre (2017–2021); North Shore University Hospital (2007); Long Island Jewish Medical Center (2007); Kaiser Permanente Oakland Medical Center (2025); Health Sciences Centre (2022–2023); Niagara Health System (2023); University Medical Center of Southern Nevada (2019); McMaster University (2018–2022)

Faculty Researcher

8 h-index 37 pubs 219 cited

Research Areas

Biomedical Subjects

Links

ORCID

OverviewAI-generated summary

Eric K. Nguyen's research focuses on the application and outcomes of stereotactic radiotherapy, particularly for oncological and neurological conditions. His work includes investigating the long-term safety and efficacy of hypofractionated stereotactic radiotherapy for benign intracranial meningiomas. Nguyen has also examined stereotactic body radiotherapy (SBRT) for spine metastases, including a review of 24 Gy in two daily fractions, and for non-spine bone metastases, identifying predictors of fracture and recurrence. His research also encompasses the utilization of SBRT for osseous low alpha-beta resistant metastases for pain relief, as outlined in the SOLAR-P study. Additionally, Nguyen has contributed to studies on the toxicity and efficacy of multitarget thoracic SBRT and the outcomes of radiation therapy combined with immunotherapy for metastatic renal cell carcinoma.